Cytologically Proven Axillary Lymph Node Metastases Are Eradicated in Patients Receiving Preoperative Chemotherapy With Concurrent Trastuzumab for HER2-Positive Breast Cancer

BACKGROUND: The axillary pathologic complete response rate (pCR) and the effect of axillary pCR on disease-free survival (DFS) was determined in patients with HER2-positive breast cancer and biopsy-proven axillary lymph node metastases who were receiving concurrent trastuzumab and neoadjuvant chemot...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancer
Glavni autori: Dominici, Laura S., Gonzalez, Viviana M. Negron, Buzdar, Aman U., Lucci, Anthony, Mittendorf, Elizabeth A., Le-Petross, Huong T., Babiera, Gildy V., Meric-Bernstam, Funda, Hunt, Kelly K., Kuerer, Henry M.
Format: Artigo
Jezik:Inglês
Izdano: 2010
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4361091/
https://ncbi.nlm.nih.gov/pubmed/20564395
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.25152
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items